<?xml version='1.0' encoding='utf-8'?>
<document id="28285369"><sentence text="Diclofenac sex-divergent drug-drug interaction with Sunitinib: pharmacokinetics and tissue distribution in male and female mice."><entity charOffset="0-10" id="DDI-PubMed.28285369.s1.e0" text="Diclofenac" /><entity charOffset="52-61" id="DDI-PubMed.28285369.s1.e1" text="Sunitinib" /><pair ddi="false" e1="DDI-PubMed.28285369.s1.e0" e2="DDI-PubMed.28285369.s1.e0" /><pair ddi="false" e1="DDI-PubMed.28285369.s1.e0" e2="DDI-PubMed.28285369.s1.e1" /></sentence><sentence text="Coadministration of diclofenac and sunitinib, tyrosine kinase inhibitor, led to sex-divergent pharmacokinetic drug-drug interaction outcomes"><entity charOffset="20-30" id="DDI-PubMed.28285369.s2.e0" text="diclofenac" /><entity charOffset="35-44" id="DDI-PubMed.28285369.s2.e1" text="sunitinib" /><entity charOffset="46-54" id="DDI-PubMed.28285369.s2.e2" text="tyrosine" /><pair ddi="false" e1="DDI-PubMed.28285369.s2.e0" e2="DDI-PubMed.28285369.s2.e0" /><pair ddi="false" e1="DDI-PubMed.28285369.s2.e0" e2="DDI-PubMed.28285369.s2.e1" /><pair ddi="false" e1="DDI-PubMed.28285369.s2.e0" e2="DDI-PubMed.28285369.s2.e2" /><pair ddi="false" e1="DDI-PubMed.28285369.s2.e1" e2="DDI-PubMed.28285369.s2.e1" /><pair ddi="false" e1="DDI-PubMed.28285369.s2.e1" e2="DDI-PubMed.28285369.s2.e2" /></sentence><sentence text=" Male and female mice were administered 60 mg/kg PO sunitinib alone (control groups) or with 30 mg/kg PO diclofenac"><entity charOffset="105-115" id="DDI-PubMed.28285369.s3.e0" text="diclofenac" /></sentence><sentence text=" Sunitinib concentration in plasma, brain, kidney and liver were determined by HPLC and non-compartmental pharmacokinetic parameters calculated"><entity charOffset="1-10" id="DDI-PubMed.28285369.s4.e0" text="Sunitinib" /></sentence><sentence text=" In male mice, diclofenac decreased AUC0→∞ 38% in plasma (p &lt; 0"><entity charOffset="15-25" id="DDI-PubMed.28285369.s5.e0" text="diclofenac" /></sentence><sentence text="05) and 24% in liver (p &lt; 0" /><sentence text="001) and 23% in kidney (p &lt; 0" /><sentence text="001)" /><sentence text=" However, AUC0→∞ remained unchanged in plasma and increased 41% in kidney (p &lt; 0" /><sentence text="001) of female mice" /><sentence text=" In brain, sunitinib exposure decreased 46% (p &lt; 0"><entity charOffset="11-20" id="DDI-PubMed.28285369.s11.e0" text="sunitinib" /></sentence><sentence text="001) and 32% (p &lt; 0" /><sentence text="001) in male and female brain respectively" /><sentence text=" Mechanistically, diclofenac increased the liver uptake efficiency in male (27%, p &lt; 0"><entity charOffset="18-28" id="DDI-PubMed.28285369.s14.e0" text="diclofenac" /></sentence><sentence text="05) and female (48%, p &lt; 0" /><sentence text="001) mice and 30% in kidney (p &lt; 0" /><sentence text="05) of male mice, probably owing to effects on efflux transporters" /><sentence text=" Sunitinib displayed sex-divergent DDI with diclofenac with probable clinical translatability due to potential different effects in male and female patients requiring careful selection of the NSAID and advanced TDM to implement a personalized treatment"><entity charOffset="1-10" id="DDI-PubMed.28285369.s18.e0" text="Sunitinib" /><entity charOffset="44-54" id="DDI-PubMed.28285369.s18.e1" text="diclofenac" /><pair ddi="false" e1="DDI-PubMed.28285369.s18.e0" e2="DDI-PubMed.28285369.s18.e0" /><pair ddi="false" e1="DDI-PubMed.28285369.s18.e0" e2="DDI-PubMed.28285369.s18.e1" /></sentence><sentence text="" /></document>